Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / news releases / KPTI - Karyopharm Therapeutics Inc. (KPTI) CEO Richard Paulson on Q1 2022 Results - Earnings Call Transcript

KPTI - Karyopharm Therapeutics Inc. (KPTI) CEO Richard Paulson on Q1 2022 Results - Earnings Call Transcript

Karyopharm Therapeutics Inc.
Karyopharm Therapeutics, Inc. (KPTI) Q1 2022 Earnings Conference Call May 05, 2022, 08:30 ET Company Participants Elhan Webb - SVP, IR Richard Paulson - President, CEO & Director Sohanya Cheng - EVP & Chief Commercial Officer Michael Mason - EVP, CFO & Treasurer Reshma Rangwala - Chief Medical Officer Patricia Judson - SVP, Medical Strategy Conference Call Participants Maurice Raycroft - Jefferies Peter Lawson - Barclays Bank Michael Ulz - Morgan Stanley Faisal Khurshid - SVB Leerink Edward White - H.C. Wainwright & Co. Eric Joseph - JPMorgan Chase & Co. Colleen Kusy - Robert W. Baird & Co. Presentation Operator Good morning, and welcome to the Karyopharm Therapeutics First Quarter 2022 Earnings Conference Call. [Operator Instructions]. I would now like to turn the conference over to Elhan Webb, Senior Vice President, Investor Relation. Please go ahead. Elhan Webb Thank you, operator. And thank you all for joining us on

For further details see:

Karyopharm Therapeutics, Inc. (KPTI) CEO Richard Paulson on Q1 2022 Results - Earnings Call Transcript
Stock Information
Company Name: Karyopharm Therapeutics Inc.
Stock Symbol: KPTI
Market: NASDAQ
Website: karyopharm.com
Menu
KPTI KPTI Quote KPTI Short KPTI News KPTI Articles KPTI Message Board
Get KPTI Alerts

News, Short Squeeze, Breakout and More Instantly...